Model for the Molecular Genetic Diagnosis of Endometrial Cancer Using K-ras Mutation Analysis

Abstract
Endometrial cancer is the most common female genital tract cancer in Western societies (1). The prognosis for endometrial cancer is closely associated with tumor stage and histology (2). Currently, almost all cases are diagnosed following presentation with postmenopausal bleeding. Although the value of screening women in the general population for endometrial cancer is questionable, there are arguments for screening selected populations, such as women who belong to cancer-susceptible families [e.g., those with the Lynch II cancer family syndrome (3)] and women who are taking tamoxifen (4).